

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway (GO:0050853) | 6.88800658 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.30593963 |
| 3 | positive regulation of B cell differentiation (GO:0045579) | 6.16224138 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.67383489 |
| 5 | regulation of B cell differentiation (GO:0045577) | 5.35220820 |
| 6 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.20061150 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.07710574 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.07710574 |
| 9 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.57883362 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.57467340 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 4.34116627 |
| 12 | negative regulation of phagocytosis (GO:0050765) | 4.33586698 |
| 13 | response to peptidoglycan (GO:0032494) | 4.33378969 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.22338494 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.22338494 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 4.22338494 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 4.22338494 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 4.22338494 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.22338494 |
| 20 | detection of other organism (GO:0098543) | 4.22008869 |
| 21 | detection of bacterium (GO:0016045) | 4.14117217 |
| 22 | negative thymic T cell selection (GO:0045060) | 4.04950193 |
| 23 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.97952959 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.95426081 |
| 25 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.89700268 |
| 26 | cellular extravasation (GO:0045123) | 3.81623342 |
| 27 | negative regulation of B cell proliferation (GO:0030889) | 3.76511917 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 3.75358853 |
| 29 | negative T cell selection (GO:0043383) | 3.75279679 |
| 30 | regulation of histone H3-K9 methylation (GO:0051570) | 3.74450845 |
| 31 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.74350709 |
| 32 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.70853424 |
| 33 | macrophage activation involved in immune response (GO:0002281) | 3.67279388 |
| 34 | detection of external biotic stimulus (GO:0098581) | 3.66615163 |
| 35 | regulation of antigen processing and presentation (GO:0002577) | 3.66245001 |
| 36 | B cell proliferation (GO:0042100) | 3.66108192 |
| 37 | mature B cell differentiation (GO:0002335) | 3.65111985 |
| 38 | positive regulation of mast cell activation (GO:0033005) | 3.64199362 |
| 39 | negative regulation of interleukin-12 production (GO:0032695) | 3.60502611 |
| 40 | negative regulation of granulocyte differentiation (GO:0030853) | 3.57494742 |
| 41 | cellular response to zinc ion (GO:0071294) | 3.57482910 |
| 42 | positive thymic T cell selection (GO:0045059) | 3.56639859 |
| 43 | B cell homeostasis (GO:0001782) | 3.54438702 |
| 44 | detection of molecule of bacterial origin (GO:0032490) | 3.54000229 |
| 45 | natural killer cell differentiation (GO:0001779) | 3.53037391 |
| 46 | neutrophil activation involved in immune response (GO:0002283) | 3.50061105 |
| 47 | T cell homeostasis (GO:0043029) | 3.49655305 |
| 48 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.49543052 |
| 49 | respiratory burst (GO:0045730) | 3.46787490 |
| 50 | lymphocyte homeostasis (GO:0002260) | 3.43431758 |
| 51 | positive regulation of histone deacetylation (GO:0031065) | 3.41287265 |
| 52 | negative regulation of histone methylation (GO:0031061) | 3.40606218 |
| 53 | T-helper 1 type immune response (GO:0042088) | 3.39973633 |
| 54 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.38750790 |
| 55 | negative regulation of cell killing (GO:0031342) | 3.38750790 |
| 56 | positive regulation of interferon-alpha production (GO:0032727) | 3.36888967 |
| 57 | neutrophil activation (GO:0042119) | 3.35958103 |
| 58 | negative regulation of T cell mediated immunity (GO:0002710) | 3.35755227 |
| 59 | T cell selection (GO:0045058) | 3.34966946 |
| 60 | thymic T cell selection (GO:0045061) | 3.33949043 |
| 61 | microglial cell activation (GO:0001774) | 3.30598457 |
| 62 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.27687070 |
| 63 | negative regulation of bone resorption (GO:0045779) | 3.27225084 |
| 64 | regulation of mast cell activation (GO:0033003) | 3.25276269 |
| 65 | defense response to protozoan (GO:0042832) | 3.25164868 |
| 66 | positive T cell selection (GO:0043368) | 3.25111361 |
| 67 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.22442209 |
| 68 | detection of biotic stimulus (GO:0009595) | 3.20823672 |
| 69 | type I interferon signaling pathway (GO:0060337) | 3.20475857 |
| 70 | cellular response to type I interferon (GO:0071357) | 3.20475857 |
| 71 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.19929018 |
| 72 | regulation of B cell proliferation (GO:0030888) | 3.19708213 |
| 73 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.19155385 |
| 74 | response to type I interferon (GO:0034340) | 3.18875910 |
| 75 | regulation of interferon-alpha production (GO:0032647) | 3.18700917 |
| 76 | positive regulation of type 2 immune response (GO:0002830) | 3.17903729 |
| 77 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.16453365 |
| 78 | regulation of superoxide anion generation (GO:0032928) | 3.16405166 |
| 79 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.16152647 |
| 80 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.16121907 |
| 81 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.14751123 |
| 82 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.14232161 |
| 83 | response to host (GO:0075136) | 3.14232161 |
| 84 | response to host defenses (GO:0052200) | 3.14232161 |
| 85 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.14200915 |
| 86 | cellular response to ethanol (GO:0071361) | 3.12327124 |
| 87 | macrophage activation (GO:0042116) | 3.11576560 |
| 88 | regulation of B cell apoptotic process (GO:0002902) | 3.09915974 |
| 89 | granulocyte activation (GO:0036230) | 3.06519400 |
| 90 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.05683636 |
| 91 | positive regulation of B cell proliferation (GO:0030890) | 3.05659376 |
| 92 | leukocyte homeostasis (GO:0001776) | 3.05110007 |
| 93 | tolerance induction (GO:0002507) | 3.03061205 |
| 94 | regulation of leukocyte degranulation (GO:0043300) | 3.02329207 |
| 95 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.02135328 |
| 96 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.00533610 |
| 97 | regulation of hypersensitivity (GO:0002883) | 2.99195636 |
| 98 | mature B cell differentiation involved in immune response (GO:0002313) | 2.98539430 |
| 99 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.98100241 |
| 100 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.97139530 |
| 101 | response to protozoan (GO:0001562) | 2.96322311 |
| 102 | myeloid cell activation involved in immune response (GO:0002275) | 2.94689936 |
| 103 | regulation of granulocyte differentiation (GO:0030852) | 2.92313835 |
| 104 | B cell activation (GO:0042113) | 2.91350030 |
| 105 | T cell migration (GO:0072678) | 2.90421471 |
| 106 | germinal center formation (GO:0002467) | 2.89301716 |
| 107 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.88527447 |
| 108 | hepatocyte apoptotic process (GO:0097284) | 2.88227108 |
| 109 | positive regulation of B cell activation (GO:0050871) | 2.88154788 |
| 110 | serine transport (GO:0032329) | 2.87747843 |
| 111 | mononuclear cell proliferation (GO:0032943) | 2.87563434 |
| 112 | pinocytosis (GO:0006907) | 2.87450369 |
| 113 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.86265098 |
| 114 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.85370439 |
| 115 | positive regulation of granulocyte differentiation (GO:0030854) | 2.82815467 |
| 116 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.80344396 |
| 117 | mast cell degranulation (GO:0043303) | 2.80055159 |
| 118 | mast cell activation involved in immune response (GO:0002279) | 2.80055159 |
| 119 | DNA unwinding involved in DNA replication (GO:0006268) | 2.79595246 |
| 120 | lymphocyte proliferation (GO:0046651) | 2.79310671 |
| 121 | B cell mediated immunity (GO:0019724) | 2.78873396 |
| 122 | myeloid dendritic cell activation (GO:0001773) | 2.78810842 |
| 123 | natural killer cell mediated immunity (GO:0002228) | 2.78298035 |
| 124 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.78298035 |
| 125 | adaptation of signaling pathway (GO:0023058) | 2.76661451 |
| 126 | B cell differentiation (GO:0030183) | 2.75835778 |
| 127 | V(D)J recombination (GO:0033151) | 2.75564010 |
| 128 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.73680066 |
| 129 | positive regulation of protein deacetylation (GO:0090312) | 2.72504376 |
| 130 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.71069432 |
| 131 | positive regulation of mast cell degranulation (GO:0043306) | 2.71069432 |
| 132 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.70637232 |
| 133 | regulation of mast cell degranulation (GO:0043304) | 2.70020956 |
| 134 | mast cell activation (GO:0045576) | 2.69555809 |
| 135 | leukocyte aggregation (GO:0070486) | 2.68780239 |
| 136 | positive regulation of Rap GTPase activity (GO:0032854) | 2.66530214 |
| 137 | positive regulation by host of viral transcription (GO:0043923) | 2.66406936 |
| 138 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.65908325 |
| 139 | positive regulation of antigen processing and presentation (GO:0002579) | 2.65806897 |
| 140 | cellular hyperosmotic response (GO:0071474) | 2.65731672 |
| 141 | response to muramyl dipeptide (GO:0032495) | 2.65131866 |
| 142 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.64301740 |
| 143 | response to host immune response (GO:0052572) | 2.64301740 |
| 144 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.63079704 |
| 145 | regulation of B cell activation (GO:0050864) | 2.62689543 |
| 146 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.62467794 |
| 147 | determination of adult lifespan (GO:0008340) | 2.61822259 |
| 148 | NIK/NF-kappaB signaling (GO:0038061) | 2.61559766 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.53531034 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.05084110 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 4.24036482 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.73972885 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.60261450 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.51512273 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.49509297 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.40227181 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.38541550 |
| 10 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.34269881 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.15974774 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.02184864 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.91799631 |
| 14 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.88195493 |
| 15 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.69533373 |
| 16 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.67904108 |
| 17 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.42615524 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.41650908 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.40580371 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.39310995 |
| 21 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.38139204 |
| 22 | MYB_26560356_Chip-Seq_TH2_Human | 2.30771996 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.29561711 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.25416779 |
| 25 | MYB_26560356_Chip-Seq_TH1_Human | 2.22674270 |
| 26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.22299590 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.21314481 |
| 28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.19565801 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 2.17618787 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.17335171 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.10654856 |
| 32 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.07915327 |
| 33 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.05880166 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93677683 |
| 35 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.91410716 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.91242995 |
| 37 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.91240116 |
| 38 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.90237914 |
| 39 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.81987654 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.80745338 |
| 41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.76267969 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.74615833 |
| 43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.70792515 |
| 44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.64301825 |
| 45 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.60763379 |
| 46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59649057 |
| 47 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57571894 |
| 48 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.53364403 |
| 49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.51768506 |
| 50 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51489160 |
| 51 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.49539071 |
| 52 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.49342807 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.48195611 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.45687377 |
| 55 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43877818 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41653635 |
| 57 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.41079352 |
| 58 | MAF_26560356_Chip-Seq_TH2_Human | 1.40837033 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35845903 |
| 60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.33665522 |
| 61 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.32266273 |
| 62 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31092860 |
| 63 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.30408508 |
| 64 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.29761603 |
| 65 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.25293031 |
| 66 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.22589553 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22523484 |
| 68 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.22446697 |
| 69 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21626739 |
| 70 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.21462130 |
| 71 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20000289 |
| 72 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18337376 |
| 73 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.18021452 |
| 74 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16998459 |
| 75 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.16547386 |
| 76 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.16181573 |
| 77 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15363822 |
| 78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.13604651 |
| 79 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.13041749 |
| 80 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12117628 |
| 81 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10093568 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09828563 |
| 83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09025140 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06086644 |
| 85 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.06023807 |
| 86 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05094824 |
| 87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99810112 |
| 88 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.99455041 |
| 89 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94753091 |
| 90 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92751508 |
| 91 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.92429219 |
| 92 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.92424423 |
| 93 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91522907 |
| 94 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.91230963 |
| 95 | GATA3_26560356_Chip-Seq_TH2_Human | 0.89588310 |
| 96 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.88070066 |
| 97 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86051644 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.85481710 |
| 99 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.85170741 |
| 100 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83001412 |
| 101 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.82155949 |
| 102 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.81770890 |
| 103 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.80748839 |
| 104 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79164035 |
| 105 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.78758593 |
| 106 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.78506932 |
| 107 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.77824554 |
| 108 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77257639 |
| 109 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76869386 |
| 110 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76709132 |
| 111 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75934820 |
| 112 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.75415587 |
| 113 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.75054698 |
| 114 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74839086 |
| 115 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.74807035 |
| 116 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74681809 |
| 117 | P300_27268052_Chip-Seq_Bcells_Human | 0.73299001 |
| 118 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73167924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.63689847 |
| 2 | MP0001800_abnormal_humoral_immune | 3.81648031 |
| 3 | MP0005387_immune_system_phenotype | 3.52225462 |
| 4 | MP0001790_abnormal_immune_system | 3.52225462 |
| 5 | MP0003303_peritoneal_inflammation | 3.34263222 |
| 6 | MP0000685_abnormal_immune_system | 3.30793332 |
| 7 | MP0002452_abnormal_antigen_presenting | 3.16339522 |
| 8 | MP0002396_abnormal_hematopoietic_system | 3.10401344 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.72457182 |
| 10 | MP0002723_abnormal_immune_serum | 2.70049673 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.67223220 |
| 12 | MP0002398_abnormal_bone_marrow | 2.66214771 |
| 13 | MP0001819_abnormal_immune_cell | 2.62782742 |
| 14 | MP0000569_abnormal_digit_pigmentation | 2.56958279 |
| 15 | MP0003436_decreased_susceptibility_to | 2.47357958 |
| 16 | MP0005671_abnormal_response_to | 2.42986209 |
| 17 | MP0000689_abnormal_spleen_morphology | 2.42922676 |
| 18 | MP0004808_abnormal_hematopoietic_stem | 2.38460933 |
| 19 | MP0000716_abnormal_immune_system | 2.36578484 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.36280963 |
| 21 | MP0009278_abnormal_bone_marrow | 2.36087312 |
| 22 | MP0002419_abnormal_innate_immunity | 2.28267102 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.26051303 |
| 24 | MP0005025_abnormal_response_to | 2.20867543 |
| 25 | MP0002722_abnormal_immune_system | 2.13487897 |
| 26 | MP0005464_abnormal_platelet_physiology | 2.12189387 |
| 27 | MP0009785_altered_susceptibility_to | 2.04585820 |
| 28 | MP0002429_abnormal_blood_cell | 1.99991027 |
| 29 | MP0005174_abnormal_tail_pigmentation | 1.87529221 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.80107982 |
| 31 | MP0001873_stomach_inflammation | 1.77883658 |
| 32 | MP0005451_abnormal_body_composition | 1.77787250 |
| 33 | MP0002405_respiratory_system_inflammati | 1.77616116 |
| 34 | MP0003183_abnormal_peptide_metabolism | 1.76665903 |
| 35 | MP0000703_abnormal_thymus_morphology | 1.75331170 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.66580537 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.66580537 |
| 38 | MP0008057_abnormal_DNA_replication | 1.66280015 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.66102428 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.59609663 |
| 41 | MP0004947_skin_inflammation | 1.59526643 |
| 42 | MP0002006_tumorigenesis | 1.56846553 |
| 43 | MP0003172_abnormal_lysosome_physiology | 1.55495287 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.55391653 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.53279303 |
| 46 | MP0010094_abnormal_chromosome_stability | 1.51763013 |
| 47 | MP0001853_heart_inflammation | 1.51411862 |
| 48 | MP0008260_abnormal_autophagy | 1.48191672 |
| 49 | MP0010307_abnormal_tumor_latency | 1.46764330 |
| 50 | MP0004510_myositis | 1.36559837 |
| 51 | MP0010352_gastrointestinal_tract_polyps | 1.36547537 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.32997293 |
| 53 | MP0003077_abnormal_cell_cycle | 1.29244830 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.27566642 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.26785866 |
| 56 | MP0004381_abnormal_hair_follicle | 1.24844456 |
| 57 | MP0000490_abnormal_crypts_of | 1.24408957 |
| 58 | MP0003111_abnormal_nucleus_morphology | 1.22043405 |
| 59 | MP0002019_abnormal_tumor_incidence | 1.22011975 |
| 60 | MP0005076_abnormal_cell_differentiation | 1.21628122 |
| 61 | MP0003866_abnormal_defecation | 1.18935448 |
| 62 | MP0006082_CNS_inflammation | 1.18720911 |
| 63 | MP0000015_abnormal_ear_pigmentation | 1.17632163 |
| 64 | MP0003075_altered_response_to | 1.16242525 |
| 65 | MP0000604_amyloidosis | 1.16098175 |
| 66 | MP0000343_altered_response_to | 1.09734038 |
| 67 | MP0008004_abnormal_stomach_pH | 1.09430176 |
| 68 | MP0003693_abnormal_embryo_hatching | 1.09223351 |
| 69 | MP0005310_abnormal_salivary_gland | 1.08909729 |
| 70 | MP0003191_abnormal_cellular_cholesterol | 1.07649061 |
| 71 | MP0006054_spinal_hemorrhage | 1.05784265 |
| 72 | MP0009764_decreased_sensitivity_to | 1.02776713 |
| 73 | MP0003566_abnormal_cell_adhesion | 1.02579342 |
| 74 | MP0008469_abnormal_protein_level | 1.01807813 |
| 75 | MP0002095_abnormal_skin_pigmentation | 0.98733903 |
| 76 | MP0001533_abnormal_skeleton_physiology | 0.98704909 |
| 77 | MP0001986_abnormal_taste_sensitivity | 0.98440010 |
| 78 | MP0002933_joint_inflammation | 0.98069110 |
| 79 | MP0003690_abnormal_glial_cell | 0.92900488 |
| 80 | MP0004883_abnormal_blood_vessel | 0.90946045 |
| 81 | MP0002009_preneoplasia | 0.86876843 |
| 82 | MP0005075_abnormal_melanosome_morpholog | 0.85955901 |
| 83 | MP0001879_abnormal_lymphatic_vessel | 0.85948349 |
| 84 | MP0003091_abnormal_cell_migration | 0.81389850 |
| 85 | MP0002928_abnormal_bile_duct | 0.80435132 |
| 86 | MP0008961_abnormal_basal_metabolism | 0.78263372 |
| 87 | MP0000350_abnormal_cell_proliferation | 0.77483852 |
| 88 | MP0002132_abnormal_respiratory_system | 0.76510137 |
| 89 | MP0009840_abnormal_foam_cell | 0.76125450 |
| 90 | MP0003448_altered_tumor_morphology | 0.74989415 |
| 91 | MP0000313_abnormal_cell_death | 0.74334867 |
| 92 | MP0009115_abnormal_fat_cell | 0.73751852 |
| 93 | MP0005621_abnormal_cell_physiology | 0.72546016 |
| 94 | MP0001915_intracranial_hemorrhage | 0.70881089 |
| 95 | MP0008058_abnormal_DNA_repair | 0.70506387 |
| 96 | MP0002136_abnormal_kidney_physiology | 0.67437938 |
| 97 | MP0000858_altered_metastatic_potential | 0.65865833 |
| 98 | MP0003828_pulmonary_edema | 0.65625981 |
| 99 | MP0000371_diluted_coat_color | 0.65345979 |
| 100 | MP0005166_decreased_susceptibility_to | 0.63268634 |
| 101 | MP0001851_eye_inflammation | 0.62402743 |
| 102 | MP0001663_abnormal_digestive_system | 0.61768817 |
| 103 | MP0008007_abnormal_cellular_replicative | 0.61376329 |
| 104 | MP0001958_emphysema | 0.60343335 |
| 105 | MP0003943_abnormal_hepatobiliary_system | 0.58903273 |
| 106 | MP0000249_abnormal_blood_vessel | 0.57068899 |
| 107 | MP0004957_abnormal_blastocyst_morpholog | 0.57012859 |
| 108 | MP0001730_embryonic_growth_arrest | 0.56950730 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.55703896 |
| 110 | MP0005647_abnormal_sex_gland | 0.55384843 |
| 111 | MP0009763_increased_sensitivity_to | 0.55028676 |
| 112 | MP0003045_fibrosis | 0.54918784 |
| 113 | MP0005164_abnormal_response_to | 0.54357370 |
| 114 | MP0008874_decreased_physiological_sensi | 0.53919845 |
| 115 | MP0003656_abnormal_erythrocyte_physiolo | 0.53792824 |
| 116 | MP0003453_abnormal_keratinocyte_physiol | 0.52351856 |
| 117 | MP0003795_abnormal_bone_structure | 0.52215914 |
| 118 | MP0003787_abnormal_imprinting | 0.51945283 |
| 119 | MP0005384_cellular_phenotype | 0.51913229 |
| 120 | MP0000920_abnormal_myelination | 0.51319834 |
| 121 | MP0002138_abnormal_hepatobiliary_system | 0.51286760 |
| 122 | MP0003724_increased_susceptibility_to | 0.51271963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 7.77329674 |
| 2 | Cellulitis (HP:0100658) | 6.64566970 |
| 3 | Verrucae (HP:0200043) | 5.36428877 |
| 4 | Papilloma (HP:0012740) | 5.36428877 |
| 5 | Colitis (HP:0002583) | 4.95044356 |
| 6 | Recurrent viral infections (HP:0004429) | 4.78506419 |
| 7 | Recurrent bronchitis (HP:0002837) | 4.66732427 |
| 8 | IgM deficiency (HP:0002850) | 4.50413389 |
| 9 | Meningitis (HP:0001287) | 4.50000337 |
| 10 | Inflammation of the large intestine (HP:0002037) | 4.42838148 |
| 11 | Recurrent abscess formation (HP:0002722) | 4.36961117 |
| 12 | Gastrointestinal inflammation (HP:0004386) | 4.35524124 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 4.25836911 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 4.24882013 |
| 15 | Osteomyelitis (HP:0002754) | 4.19091954 |
| 16 | Gastrointestinal stroma tumor (HP:0100723) | 4.13958116 |
| 17 | Thyroiditis (HP:0100646) | 4.08644516 |
| 18 | B lymphocytopenia (HP:0010976) | 3.92827136 |
| 19 | Abnormality of B cell number (HP:0010975) | 3.92827136 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 3.84744682 |
| 21 | Recurrent fungal infections (HP:0002841) | 3.80875315 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.76461144 |
| 23 | Chronic otitis media (HP:0000389) | 3.70308428 |
| 24 | Recurrent sinusitis (HP:0011108) | 3.58268096 |
| 25 | Chronic sinusitis (HP:0011109) | 3.55950685 |
| 26 | Abnormality of the fingertips (HP:0001211) | 3.53216293 |
| 27 | Small epiphyses (HP:0010585) | 3.44725534 |
| 28 | Recurrent pneumonia (HP:0006532) | 3.42958833 |
| 29 | Sepsis (HP:0100806) | 3.31946378 |
| 30 | Lymphopenia (HP:0001888) | 3.22801168 |
| 31 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.14324375 |
| 32 | Recurrent cutaneous fungal infections (HP:0011370) | 3.14324375 |
| 33 | Recurrent skin infections (HP:0001581) | 3.13578489 |
| 34 | Recurrent lower respiratory tract infections (HP:0002783) | 3.11717432 |
| 35 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.11005445 |
| 36 | Eczematoid dermatitis (HP:0000976) | 3.07043112 |
| 37 | Systemic lupus erythematosus (HP:0002725) | 3.05091065 |
| 38 | Vasculitis (HP:0002633) | 3.02937772 |
| 39 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.02235157 |
| 40 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.02235157 |
| 41 | Abnormality of glycolipid metabolism (HP:0010969) | 3.02235157 |
| 42 | Optic neuritis (HP:0100653) | 3.01542606 |
| 43 | Retrobulbar optic neuritis (HP:0100654) | 3.01542606 |
| 44 | Orchitis (HP:0100796) | 2.96681670 |
| 45 | Autoimmune thrombocytopenia (HP:0001973) | 2.93407574 |
| 46 | Mediastinal lymphadenopathy (HP:0100721) | 2.84068774 |
| 47 | Mitral stenosis (HP:0001718) | 2.80716762 |
| 48 | Pulmonary infiltrates (HP:0002113) | 2.80439364 |
| 49 | Emphysema (HP:0002097) | 2.79922130 |
| 50 | Gastrointestinal infarctions (HP:0005244) | 2.78178210 |
| 51 | Urticaria (HP:0001025) | 2.77901210 |
| 52 | Hemoptysis (HP:0002105) | 2.71143284 |
| 53 | Recurrent otitis media (HP:0000403) | 2.63970374 |
| 54 | Vertebral arch anomaly (HP:0008438) | 2.63423724 |
| 55 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.62002713 |
| 56 | Abnormality of the intervertebral disk (HP:0005108) | 2.59223678 |
| 57 | Obstructive lung disease (HP:0006536) | 2.59203846 |
| 58 | Chronic obstructive pulmonary disease (HP:0006510) | 2.59203846 |
| 59 | Thrombocytosis (HP:0001894) | 2.58650307 |
| 60 | Spontaneous hematomas (HP:0007420) | 2.56080927 |
| 61 | Bronchitis (HP:0012387) | 2.54918834 |
| 62 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.54099343 |
| 63 | Stomatitis (HP:0010280) | 2.51738434 |
| 64 | Restrictive lung disease (HP:0002091) | 2.51663459 |
| 65 | T lymphocytopenia (HP:0005403) | 2.50686019 |
| 66 | Abnormality of T cells (HP:0002843) | 2.48321154 |
| 67 | IgA deficiency (HP:0002720) | 2.46734426 |
| 68 | Hematochezia (HP:0002573) | 2.46604646 |
| 69 | Periodontitis (HP:0000704) | 2.45685742 |
| 70 | Abnormality of the prostate (HP:0008775) | 2.45293593 |
| 71 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.44454504 |
| 72 | Abnormality of T cell physiology (HP:0011840) | 2.42314210 |
| 73 | Prolonged bleeding time (HP:0003010) | 2.41369805 |
| 74 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.39221797 |
| 75 | Abnormality of T cell number (HP:0011839) | 2.33599163 |
| 76 | Ulnar bowing (HP:0003031) | 2.32570951 |
| 77 | Interstitial pulmonary disease (HP:0006530) | 2.32207915 |
| 78 | Skin rash (HP:0000988) | 2.29779583 |
| 79 | Abnormality of the peritoneum (HP:0002585) | 2.28413559 |
| 80 | Skin ulcer (HP:0200042) | 2.26384456 |
| 81 | Chronic diarrhea (HP:0002028) | 2.25555817 |
| 82 | Loss of speech (HP:0002371) | 2.24567581 |
| 83 | Lymphoma (HP:0002665) | 2.24194469 |
| 84 | Dysostosis multiplex (HP:0000943) | 2.23560789 |
| 85 | Flattened epiphyses (HP:0003071) | 2.22591009 |
| 86 | Leukopenia (HP:0001882) | 2.18521357 |
| 87 | Keratoconjunctivitis sicca (HP:0001097) | 2.17524397 |
| 88 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.17178958 |
| 89 | Abnormality of the pleura (HP:0002103) | 2.15979625 |
| 90 | Pustule (HP:0200039) | 2.14157641 |
| 91 | Eosinophilia (HP:0001880) | 2.12887703 |
| 92 | IgG deficiency (HP:0004315) | 2.12579389 |
| 93 | Hypoplasia of the thymus (HP:0000778) | 2.11424964 |
| 94 | Increased IgE level (HP:0003212) | 2.09952434 |
| 95 | Viral hepatitis (HP:0006562) | 2.09160254 |
| 96 | Nasal polyposis (HP:0100582) | 2.07349773 |
| 97 | Combined immunodeficiency (HP:0005387) | 2.04458703 |
| 98 | Amaurosis fugax (HP:0100576) | 2.03484917 |
| 99 | Severe combined immunodeficiency (HP:0004430) | 2.02836848 |
| 100 | Increased IgM level (HP:0003496) | 2.00609683 |
| 101 | Long eyelashes (HP:0000527) | 2.00541538 |
| 102 | Pulmonary embolism (HP:0002204) | 1.98513150 |
| 103 | Autoimmune hemolytic anemia (HP:0001890) | 1.98020287 |
| 104 | Keratoconjunctivitis (HP:0001096) | 1.97827078 |
| 105 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.96413905 |
| 106 | Absent epiphyses (HP:0010577) | 1.96413905 |
| 107 | Fatigue (HP:0012378) | 1.96217583 |
| 108 | Encephalitis (HP:0002383) | 1.94921329 |
| 109 | Arthralgia (HP:0002829) | 1.93318173 |
| 110 | Premature loss of primary teeth (HP:0006323) | 1.92860161 |
| 111 | Arthropathy (HP:0003040) | 1.92374972 |
| 112 | Myositis (HP:0100614) | 1.91788968 |
| 113 | Slow saccadic eye movements (HP:0000514) | 1.91534390 |
| 114 | Gingivitis (HP:0000230) | 1.91438740 |
| 115 | Abnormality of macrophages (HP:0004311) | 1.90483364 |
| 116 | Neutropenia (HP:0001875) | 1.89685552 |
| 117 | Acute lymphatic leukemia (HP:0006721) | 1.88142102 |
| 118 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.88127415 |
| 119 | Abnormal platelet function (HP:0011869) | 1.88013292 |
| 120 | Impaired platelet aggregation (HP:0003540) | 1.88013292 |
| 121 | Granulocytopenia (HP:0001913) | 1.87010971 |
| 122 | Increased density of long bones (HP:0006392) | 1.86639148 |
| 123 | Chest pain (HP:0100749) | 1.84201047 |
| 124 | Abnormality of the nasal mucosa (HP:0000433) | 1.82532213 |
| 125 | Gingival bleeding (HP:0000225) | 1.80421983 |
| 126 | Increased cerebral lipofuscin (HP:0011813) | 1.80044220 |
| 127 | Leukocytosis (HP:0001974) | 1.80040542 |
| 128 | Epistaxis (HP:0000421) | 1.79339988 |
| 129 | Cutaneous melanoma (HP:0012056) | 1.78760677 |
| 130 | Arterial thrombosis (HP:0004420) | 1.74917352 |
| 131 | Abnormality of eosinophils (HP:0001879) | 1.74622663 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K10 | 5.35033960 |
| 2 | MAP4K1 | 5.06240432 |
| 3 | EEF2K | 3.73852752 |
| 4 | PRPF4B | 2.99454174 |
| 5 | ERN1 | 2.85362413 |
| 6 | GRK6 | 2.71146909 |
| 7 | CSF1R | 2.68821871 |
| 8 | RIPK4 | 2.44093581 |
| 9 | SIK2 | 2.31866386 |
| 10 | SYK | 2.24051704 |
| 11 | BTK | 2.22233425 |
| 12 | BLK | 2.21545888 |
| 13 | STK10 | 2.08635655 |
| 14 | CDK12 | 2.02898258 |
| 15 | KIT | 1.96958496 |
| 16 | TYK2 | 1.93170087 |
| 17 | LRRK2 | 1.71166158 |
| 18 | FES | 1.67234416 |
| 19 | CLK1 | 1.60599459 |
| 20 | PKN2 | 1.56963662 |
| 21 | MAP3K14 | 1.53137460 |
| 22 | NEK2 | 1.49760930 |
| 23 | HCK | 1.48526796 |
| 24 | BMPR2 | 1.40930040 |
| 25 | CDC42BPA | 1.38716884 |
| 26 | NEK9 | 1.37723417 |
| 27 | TRIB3 | 1.37096990 |
| 28 | MAP3K13 | 1.34805799 |
| 29 | JAK1 | 1.33102271 |
| 30 | LYN | 1.28792079 |
| 31 | IRAK4 | 1.28655440 |
| 32 | STK4 | 1.28187521 |
| 33 | TBK1 | 1.26691350 |
| 34 | PIM1 | 1.25060915 |
| 35 | JAK3 | 1.22678098 |
| 36 | ZAP70 | 1.19453464 |
| 37 | PIK3CG | 1.17328342 |
| 38 | CDK4 | 1.16749263 |
| 39 | BRD4 | 1.12259148 |
| 40 | TXK | 1.09887791 |
| 41 | CSK | 1.09187232 |
| 42 | SMG1 | 1.07246450 |
| 43 | TGFBR2 | 1.05905031 |
| 44 | IKBKB | 1.05646452 |
| 45 | TAOK3 | 1.02749791 |
| 46 | LCK | 1.01178270 |
| 47 | TEC | 0.99172715 |
| 48 | CAMK1D | 0.98598717 |
| 49 | CAMK1G | 0.96647669 |
| 50 | RPS6KB2 | 0.96147788 |
| 51 | FLT3 | 0.93961123 |
| 52 | MAP2K3 | 0.91804622 |
| 53 | MARK3 | 0.89570973 |
| 54 | ITK | 0.88280913 |
| 55 | FGFR3 | 0.86282237 |
| 56 | TNK2 | 0.85091101 |
| 57 | MATK | 0.84817282 |
| 58 | MAP3K1 | 0.83480930 |
| 59 | IKBKE | 0.82715016 |
| 60 | CDK9 | 0.82210883 |
| 61 | HIPK2 | 0.81987228 |
| 62 | SCYL2 | 0.81783626 |
| 63 | CDC7 | 0.81735379 |
| 64 | TLK1 | 0.81221822 |
| 65 | KSR2 | 0.78678905 |
| 66 | PDPK1 | 0.77725054 |
| 67 | IRAK3 | 0.76820594 |
| 68 | CDK6 | 0.74927146 |
| 69 | GRK7 | 0.73367176 |
| 70 | MAP3K11 | 0.72779462 |
| 71 | MARK2 | 0.71064152 |
| 72 | MAPK12 | 0.70098178 |
| 73 | MAPK11 | 0.68726776 |
| 74 | PTK6 | 0.68586685 |
| 75 | CHUK | 0.66958203 |
| 76 | RPS6KA4 | 0.65478202 |
| 77 | MAPK4 | 0.64716555 |
| 78 | MAP3K3 | 0.64137662 |
| 79 | IRAK2 | 0.64064491 |
| 80 | YES1 | 0.63860254 |
| 81 | IRAK1 | 0.62795619 |
| 82 | MAP3K8 | 0.62567893 |
| 83 | EPHB1 | 0.61493022 |
| 84 | TRPM7 | 0.60743664 |
| 85 | MAP3K7 | 0.58080826 |
| 86 | ALK | 0.58066073 |
| 87 | TAOK2 | 0.57883313 |
| 88 | TAOK1 | 0.57564006 |
| 89 | ATR | 0.55973382 |
| 90 | EIF2AK3 | 0.53573680 |
| 91 | SGK2 | 0.52087649 |
| 92 | PDK1 | 0.51415926 |
| 93 | MAP3K5 | 0.50983990 |
| 94 | JAK2 | 0.50983417 |
| 95 | TTN | 0.50060243 |
| 96 | NME2 | 0.49086848 |
| 97 | CAMKK1 | 0.48699603 |
| 98 | RPS6KL1 | 0.48678609 |
| 99 | RPS6KC1 | 0.48678609 |
| 100 | MELK | 0.46697504 |
| 101 | FGR | 0.45676549 |
| 102 | MAPK7 | 0.44681671 |
| 103 | FRK | 0.43707213 |
| 104 | PRKCQ | 0.43083562 |
| 105 | MAPKAPK3 | 0.42948845 |
| 106 | ABL1 | 0.42910218 |
| 107 | FGFR4 | 0.41988014 |
| 108 | SGK3 | 0.40660843 |
| 109 | MOS | 0.40533762 |
| 110 | SIK3 | 0.38348689 |
| 111 | SIK1 | 0.37716784 |
| 112 | PASK | 0.37238206 |
| 113 | STK3 | 0.36516655 |
| 114 | EGFR | 0.35895178 |
| 115 | CDK19 | 0.35706758 |
| 116 | MAPKAPK2 | 0.35233042 |
| 117 | TESK2 | 0.34014278 |
| 118 | ICK | 0.33521581 |
| 119 | CAMKK2 | 0.33377584 |
| 120 | RPS6KA2 | 0.33237760 |
| 121 | MST4 | 0.33201164 |
| 122 | PRKCH | 0.33100254 |
| 123 | STK24 | 0.32770082 |
| 124 | CHEK1 | 0.32203475 |
| 125 | DYRK1B | 0.31750488 |
| 126 | RPS6KA6 | 0.30910245 |
| 127 | FYN | 0.29919388 |
| 128 | PRKD1 | 0.29137747 |
| 129 | PRKD2 | 0.27677356 |
| 130 | MTOR | 0.27351027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.84519162 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.55380536 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.46340332 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.24783698 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.19127767 |
| 6 | Asthma_Homo sapiens_hsa05310 | 3.17450472 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.57826376 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.54159964 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.47405945 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.41487539 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.24290831 |
| 12 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 2.09180847 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.00828157 |
| 14 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.89830338 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.84272142 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.81865495 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.70540507 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.69545307 |
| 19 | DNA replication_Homo sapiens_hsa03030 | 1.68112000 |
| 20 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.64782607 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.64646369 |
| 22 | Base excision repair_Homo sapiens_hsa03410 | 1.62498615 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.57098154 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.49660392 |
| 25 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.49550190 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.47797192 |
| 27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.47105433 |
| 28 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.46246892 |
| 29 | Phagosome_Homo sapiens_hsa04145 | 1.40886330 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.40661977 |
| 31 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.36049652 |
| 32 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.32506715 |
| 33 | Mismatch repair_Homo sapiens_hsa03430 | 1.32284280 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.31625167 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.30292778 |
| 36 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.29364478 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.28954949 |
| 38 | Platelet activation_Homo sapiens_hsa04611 | 1.28386960 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.27926121 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.27226868 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26010053 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.25399518 |
| 43 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.25183435 |
| 44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.21628816 |
| 45 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.18912290 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.18571607 |
| 47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.14940793 |
| 48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.14807481 |
| 49 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.08264794 |
| 50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.01443621 |
| 51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.98965145 |
| 52 | Pertussis_Homo sapiens_hsa05133 | 0.97261313 |
| 53 | Malaria_Homo sapiens_hsa05144 | 0.94956995 |
| 54 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.94500445 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 0.93050341 |
| 56 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.92301678 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.91778568 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.90392546 |
| 59 | Legionellosis_Homo sapiens_hsa05134 | 0.88954573 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88922739 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88807429 |
| 62 | Homologous recombination_Homo sapiens_hsa03440 | 0.87877363 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.86940011 |
| 64 | HTLV-I infection_Homo sapiens_hsa05166 | 0.86748209 |
| 65 | Glioma_Homo sapiens_hsa05214 | 0.85758678 |
| 66 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85049024 |
| 67 | Cell cycle_Homo sapiens_hsa04110 | 0.85010666 |
| 68 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.84082985 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82734597 |
| 70 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.82290567 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82251816 |
| 72 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.82149027 |
| 73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.80021193 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.75300728 |
| 75 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70589499 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69733827 |
| 77 | Salmonella infection_Homo sapiens_hsa05132 | 0.69384923 |
| 78 | Colorectal cancer_Homo sapiens_hsa05210 | 0.68363248 |
| 79 | Spliceosome_Homo sapiens_hsa03040 | 0.65738343 |
| 80 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.64844108 |
| 81 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64577660 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.64169254 |
| 83 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62088571 |
| 84 | Lysosome_Homo sapiens_hsa04142 | 0.61384133 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59174834 |
| 86 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.57698801 |
| 87 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56098850 |
| 88 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55908744 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54906978 |
| 90 | Prostate cancer_Homo sapiens_hsa05215 | 0.54106902 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53852570 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52144530 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50425880 |
| 94 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48863324 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48522587 |
| 96 | Ribosome_Homo sapiens_hsa03010 | 0.47361739 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46411126 |
| 98 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.46131039 |
| 99 | Alcoholism_Homo sapiens_hsa05034 | 0.45049226 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.43539321 |
| 101 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42120308 |
| 102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.40861052 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40261902 |
| 104 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.39017061 |
| 105 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38913027 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38283985 |
| 107 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.38183379 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38180343 |
| 109 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37791669 |
| 110 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.36922599 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36698433 |
| 112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35791025 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35178121 |
| 114 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32119543 |
| 115 | Amoebiasis_Homo sapiens_hsa05146 | 0.30545326 |
| 116 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.29989135 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28866513 |
| 118 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.27555180 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26698254 |
| 120 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.22037402 |
| 121 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.19503482 |
| 122 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18963262 |
| 123 | Long-term potentiation_Homo sapiens_hsa04720 | 0.17088919 |

